BW-1003C87 (Ethylsulfate)
BW-1003C87 Ethylsulfate is a glutamate release inhibitor. BW-1003C87 Ethylsulfate exhibit neuroprotective effect. BW-1003C87 Ethylsulfate can elevate seizure threshold. BW-1003C87 Ethylsulfate can be used for the research of neurological disease, such as ischemic and seizure[1][2][3].
Product Specifications
CAS Number
144425-86-5
UNSPSC
12352005
Target
Others
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
CCS(=O)(O)=O.NC1=NC(N)=NC=C1C2=C(C(Cl)=CC(Cl)=C2)Cl
Molecular Formula
C12H13Cl3N4O3S
Molecular Weight
399.68
References & Citations
[1]Gilland E, et al. Hypoxic-ischemic injury in the neonatal rat brain: effects of pre- and post-treatment with the glutamate release inhibitor BW1003C87. Brain Res Dev Brain Res. 1994 Nov 18;83 (1) :79-84.|[2]Morimoto K, et al. BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy. Eur J Pharmacol. 1997 Nov 19;339 (1) :11-5.|[3]Gaspary HL, et al. BW1003C87 and NBQX but not CGS19755 reduce glutamate release and cerebral ischemic necrosis. Eur J Pharmacol. 1994 Sep 12;262 (3) :197-203.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
037252-FITC 200 µL
KAL1, NT (KAL1, ADMLX, KAL, KALIG1, Anosmin-1, Adhesion molecule-like X-linked, Kallmann syndrome protein) (FITC) discontinued
Sign In for Pricing
View Details 
